Category: DMD Treatment and Therapeutic Approaches
Exon 53 Skipping
A treatment strategy that targets exon 53 during dystrophin RNA processing to restore the reading frame in certain DMD mutations. Eligibility depends on the exact genetic variant, and the presence of an exon 53 deletion alone does not automatically establish suitability for every exon-skipping approach.
- Updated November 3, 2026